Found: 129
Select item for more details and to access through your institution.
Clinical impact of postprogression survival for overall survival in elderly patients (aged 75 years or older) with advanced nonsmall cell lung cancer.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Prognostic significance of diabetes mellitus in locally advanced non-small cell lung cancer.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Efficacy and safety of amrubicin monotherapy after atezolizumab plus carboplatin and etoposide in patients with relapsed small-cell lung cancer.
- Published in:
- Investigational New Drugs, 2022, v. 40, n. 5, p. 1066, doi. 10.1007/s10637-022-01269-9
- By:
- Publication type:
- Article
Osimertinib for patients with poor performance status and EGFR T790M mutation-positive advanced non-small cell lung cancer: a phase II clinical trial.
- Published in:
- Investigational New Drugs, 2020, v. 38, n. 6, p. 1854, doi. 10.1007/s10637-020-00943-0
- By:
- Publication type:
- Article
Comparative analysis of different response criteria at early phase after PD-1 blockade in non-small lung cancer.
- Published in:
- Cancer Imaging, 2023, v. 23, n. 1, p. 1, doi. 10.1186/s40644-023-00538-x
- By:
- Publication type:
- Article
Post-progression survival is strongly linked to overall survival in refractory small-cell lung cancer patients who received amrubicin.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Efficacy and Feasibility of Programmed Death-1/Programmed Death Ligand-1 Blockade Therapy in Non-Small Cell Lung Cancer Patients With High Antinuclear Antibody Titers.
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. N.PAG, doi. 10.3389/fonc.2021.610952
- By:
- Publication type:
- Article
Clinical features of patients with invasive thymoma: A retrospective analysis of 61 cases.
- Published in:
- Surgical Practice, 2013, v. 17, n. 4, p. 140, doi. 10.1111/1744-1633.12026
- By:
- Publication type:
- Article
L-type amino acid transporter 1 (LAT1) is frequently expressed in thymic carcinomas but is absent in thymomas.
- Published in:
- Journal of Surgical Oncology, 2009, v. 99, n. 7, p. 433, doi. 10.1002/jso.21277
- By:
- Publication type:
- Article
Clinical Outcomes of Postoperative Adjuvant Chemotherapy for Surgically Resected High-Grade Pulmonary Neuroendocrine Carcinoma.
- Published in:
- Chemotherapy (0009-3157), 2022, v. 67, n. 3, p. 142, doi. 10.1159/000524077
- By:
- Publication type:
- Article
Efficacy and Safety of Anti-Programed Death-1 Blockade in Previously Treated Large-Cell Neuroendocrine Carcinoma.
- Published in:
- Chemotherapy (0009-3157), 2021, v. 66, n. 3, p. 65, doi. 10.1159/000514841
- By:
- Publication type:
- Article
Phase II Study of Weekly Nanoparticle Albumin-Bound Paclitaxel as Second- or Third-Line Therapy in Patients with Advanced Non-Small Cell Lung Cancer.
- Published in:
- Chemotherapy (0009-3157), 2020, v. 65, n. 1-2, p. 21, doi. 10.1159/000508715
- By:
- Publication type:
- Article
Clinical Impact of Post-Progression Survival on Overall Survival in Elderly Patients with Non-Small-Cell Lung Cancer Harboring Sensitive EGFR Mutations Treated with First-Line EGFR Tyrosine Kinase Inhibitors.
- Published in:
- Chemotherapy (0009-3157), 2018, v. 63, n. 3, p. 181, doi. 10.1159/000490949
- By:
- Publication type:
- Article
Post-Progression Survival Associated with Overall Survival in Patients with Advanced Non-Small-Cell Lung Cancer Receiving Docetaxel Monotherapy as Second-Line Chemotherapy.
- Published in:
- Chemotherapy (0009-3157), 2017, v. 62, n. 4, p. 205, doi. 10.1159/000456534
- By:
- Publication type:
- Article
Dramatic Response of S-1 Administration to Chemorefractory Advanced Thymic Cancer.
- Published in:
- Chemotherapy (0009-3157), 2015, v. 60, n. 5/6, p. 356, doi. 10.1159/000437289
- By:
- Publication type:
- Article
Efficacy and Safety of Platinum Combination Chemotherapy Re-Challenge for Relapsed Patients with Non-Small-Cell Lung Cancer after Postoperative Adjuvant Chemotherapy of Cisplatin plus Vinorelbine.
- Published in:
- Chemotherapy (0009-3157), 2014, v. 59, n. 4, p. 307, doi. 10.1159/000356155
- By:
- Publication type:
- Article
Efficacy and Safety of Naldemedine Administration for Opioid-Induced Constipation in Cancer Patients with Poor Performance Status.
- Published in:
- Journal of Palliative Medicine, 2023, v. 26, n. 4, p. 548, doi. 10.1089/jpm.2022.0495
- By:
- Publication type:
- Article
Management of Lung Cancer-Associated Malignant Pericardial Effusion with Intrapericardial Administration of Carboplatin: A Retrospective Study.
- Published in:
- Current Oncology, 2022, v. 29, n. 1, p. 163, doi. 10.3390/curroncol29010015
- By:
- Publication type:
- Article
Unfavorable impact of cancer cachexia on activity of daily living and need for inpatient care in elderly patients with advanced non-small-cell lung cancer in Japan: a prospective longitudinal observational study.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Cementogenesis Examined from the Viewpoint of Microcirculation.
- Published in:
- International Journal of Periodontics & Restorative Dentistry, 2009, v. 29, n. 3, p. 266
- By:
- Publication type:
- Article
Clinical Utility of Inflammatory and Nutritious Index as Therapeutic Prediction of Nivolumab plus Ipilimumab in Advanced Non-Small Cell Lung Cancer.
- Published in:
- Oncology, 2024, v. 102, n. 3, p. 271, doi. 10.1159/000534169
- By:
- Publication type:
- Article
Prognostic Potential of the Prognostic Nutritional Index in Non-Small Cell Lung Cancer Patients Receiving Pembrolizumab Combination Therapy with Carboplatin and Paclitaxel/Nab-Paclitaxel.
- Published in:
- Oncology, 2024, v. 102, n. 1, p. 30, doi. 10.1159/000533604
- By:
- Publication type:
- Article
Post-Progression Survival Highly Influences Overall Survival in Driver Gene Mutation/Translocation Negative or Unknown Type of Non-Small Cell Lung Cancer.
- Published in:
- Oncology, 2022, v. 100, n. 2, p. 89, doi. 10.1159/000521141
- By:
- Publication type:
- Article
Post-Progression Survival Influences Overall Survival among Patients with Advanced Non-Small Cell Lung Cancer Undergoing First-Line Pembrolizumab Monotherapy.
- Published in:
- Oncology, 2021, v. 99, n. 9, p. 562, doi. 10.1159/000516745
- By:
- Publication type:
- Article
Metachronous lesions in the orbit, retroperitoneum, and pleura of mucosa‐associated lymphoid tissue lymphoma: A case report.
- Published in:
- Cancer Reports, 2022, v. 5, n. 10, p. 1, doi. 10.1002/cnr2.1689
- By:
- Publication type:
- Article
Clinical impact of inflammatory and nutrition index based on metabolic tumor activity in non‑small cell lung cancer treated with immunotherapy.
- Published in:
- Oncology Letters, 2024, v. 27, n. 3, p. N.PAG, doi. 10.3892/ol.2024.14243
- By:
- Publication type:
- Article
Intermittent administration of atezolizumab with combined carboplatin and etoposide therapy for patients with extensive‑disease small cell lung cancer.
- Published in:
- Oncology Letters, 2023, v. 25, n. 3, p. N.PAG, doi. 10.3892/ol.2023.13696
- By:
- Publication type:
- Article
Prognostic effect of class III β-tubulin and Topoisomerase-II in patients with advanced thymic carcinoma who received combination chemotherapy, including taxanes or topoisomerase-II inhibitors.
- Published in:
- Oncology Letters, 2017, v. 14, n. 2, p. 2369, doi. 10.3892/ol.2017.6419
- By:
- Publication type:
- Article
Prospective exploratory study of gemcitabine and S-1 against elderly patients with advanced non-small cell lung cancer.
- Published in:
- Oncology Letters, 2017, v. 14, n. 1, p. 1123, doi. 10.3892/ol.2017.6259
- By:
- Publication type:
- Article
Clinical significance of antinuclear antibody as prognostic marker for first-line pembrolizumab in advanced non-small cell lung cancer.
- Published in:
- International Journal of Clinical Oncology, 2024, v. 29, n. 2, p. 124, doi. 10.1007/s10147-023-02445-4
- By:
- Publication type:
- Article
Opioid-induced constipation in patients with cancer pain in Japan (OIC-J study): a post hoc subgroup analysis of patients with gastrointestinal cancer.
- Published in:
- International Journal of Clinical Oncology, 2021, v. 26, n. 1, p. 104, doi. 10.1007/s10147-020-01790-y
- By:
- Publication type:
- Article
A phase I and extension study of S-1 and carboplatin for previously untreated patients aged 75 years or more with advanced non-small cell lung cancer -TCOG 1101-.
- Published in:
- International Journal of Clinical Oncology, 2020, v. 25, n. 5, p. 867, doi. 10.1007/s10147-020-01629-6
- By:
- Publication type:
- Article
High expression of GRP78/BiP as a novel predictor of favorable outcomes in patients with advanced thymic carcinoma.
- Published in:
- International Journal of Clinical Oncology, 2017, v. 22, n. 5, p. 872, doi. 10.1007/s10147-017-1142-x
- By:
- Publication type:
- Article
Phase I dose escalation study of amrubicin plus paclitaxel in previously treated advanced non-small cell lung cancer.
- Published in:
- International Journal of Clinical Oncology, 2016, v. 21, n. 2, p. 240, doi. 10.1007/s10147-015-0883-7
- By:
- Publication type:
- Article
The effect of gefitinib in patients with postoperative recurrent non-small cell lung cancer harboring mutations of the epidermal growth factor receptor.
- Published in:
- International Journal of Clinical Oncology, 2015, v. 20, n. 4, p. 668, doi. 10.1007/s10147-014-0761-8
- By:
- Publication type:
- Article
Efficacy and safety of first-line pembrolizumab monotherapy in elderly patients (aged ≥ 75 years) with non-small cell lung cancer.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2020, v. 146, n. 2, p. 457, doi. 10.1007/s00432-019-03072-1
- By:
- Publication type:
- Article
Low‐Dose Olanzapine Plus Granisetron and Dexamethasone for Carboplatin‐Induced Nausea and Vomiting in Patients with Thoracic Malignancies: A Prospective Multicenter Phase II Trial.
- Published in:
- Oncologist, 2021, v. 26, n. 6, p. e1066, doi. 10.1002/onco.13772
- By:
- Publication type:
- Article
Osimertinib in Elderly Patients with Epidermal Growth Factor Receptor T790M‐Positive Non‐Small‐Cell Lung Cancer Who Progressed During Prior Treatment: A Phase II Trial.
- Published in:
- Oncologist, 2019, v. 24, n. 5, p. 593, doi. 10.1634/theoncologist.2019-0003
- By:
- Publication type:
- Article
Prognostic Factors and Efficacy of First‐Line Chemotherapy in Patients with Advanced Thymic Carcinoma: A Retrospective Analysis of 286 Patients from NEJ023 Study.
- Published in:
- Oncologist, 2018, v. 23, n. 10, p. 1210, doi. 10.1634/theoncologist.2017-0586
- By:
- Publication type:
- Article
Incidence of opioid‐induced constipation in Japanese patients with cancer pain: A prospective observational cohort study.
- Published in:
- Cancer Medicine, 2019, v. 8, n. 10, p. 4883, doi. 10.1002/cam4.2341
- By:
- Publication type:
- Article
Pretreatment glasgow prognostic score predicts survival among patients administered first-line atezolizumab plus carboplatin and etoposide for small cell lung cancer.
- Published in:
- Frontiers in Oncology, 2023, v. 13, p. 1, doi. 10.3389/fonc.2022.1080729
- By:
- Publication type:
- Article
Clinicopathological impact of VEGFR2 and VEGF‐C in patients with EGFR‐major mutant NSCLC receiving osimertinib.
- Published in:
- Thoracic Cancer, 2023, v. 14, n. 29, p. 2950, doi. 10.1111/1759-7714.15082
- By:
- Publication type:
- Article
Using the neutrophil‐to‐lymphocyte ratio to predict the outcome of individuals with nonsquamous non‐small cell lung cancer receiving pembrolizumab plus platinum and pemetrexed.
- Published in:
- Thoracic Cancer, 2023, v. 14, n. 25, p. 2567, doi. 10.1111/1759-7714.15036
- By:
- Publication type:
- Article
Post‐progression survival after atezolizumab plus carboplatin and etoposide as first‐line chemotherapy in small cell lung cancer has a significant impact on overall survival.
- Published in:
- Thoracic Cancer, 2022, v. 13, n. 19, p. 2776, doi. 10.1111/1759-7714.14621
- By:
- Publication type:
- Article
A retrospective study of the efficacy and safety of naldemedine for opioid‐induced constipation in thoracic cancer patients.
- Published in:
- Thoracic Cancer, 2022, v. 13, n. 16, p. 2301, doi. 10.1111/1759-7714.14557
- By:
- Publication type:
- Article
Pretreatment body mass index predicts survival among patients administered nivolumab monotherapy for pretreated non‐small cell lung cancer.
- Published in:
- Thoracic Cancer, 2022, v. 13, n. 10, p. 1479, doi. 10.1111/1759-7714.14417
- By:
- Publication type:
- Article
Course of postoperative relapse in non‐small cell lung cancer is strongly associated with post‐progression survival.
- Published in:
- Thoracic Cancer, 2021, v. 12, n. 20, p. 2740, doi. 10.1111/1759-7714.14119
- By:
- Publication type:
- Article
The relationship between connective tissue and its microvasculature in the healthy dog gingiva.
- Published in:
- Journal of Periodontal Research, 1989, v. 24, n. 1, p. 45, doi. 10.1111/j.1600-0765.1989.tb00856.x
- By:
- Publication type:
- Article
Progression-free survival, post-progression survival, and tumor response as surrogate markers for overall survival in patients with extensive small cell lung cancer.
- Published in:
- Annals of Thoracic Medicine, 2015, v. 10, n. 1, p. 61, doi. 10.4103/1817-1737.146885
- By:
- Publication type:
- Article
A Retrospective Study of the Efficacy and Safety of Naldemedine for Treatment of Opioid-Induced Constipation in Patients with Hepatobiliary Pancreatic Cancer.
- Published in:
- Medicina (1010660X), 2023, v. 59, n. 3, p. 492, doi. 10.3390/medicina59030492
- By:
- Publication type:
- Article